QGel SA

Swiss Biotech Association

Not a member

QGel provides a functional solution to precision medicine with its ability to grow, and test drugs on, patient cancer cells derived from patient tissue biopsies, aka organoids, in its proprietary hydrogel technology, in a way that maintains the complex cancer biology of that specific patient.

http://www.qgelbio.com

Location

EPFL Innovation Park, 1015 Lausanne

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2009
Number of employees in Switzerland

20-49

Key business

Core competencies

You may also be interested in

SIX

The Swiss Stock Exchange, representing more than a third of the European life sciences market capitalization and accounting for around 35% of the total market capitalization (as of 7 April 2021), the exchange is one of Europe’s leading listing venues for biotech companies.
Zürich

Not a member

Adiposs

Adiposs is a medtech start-up company, a spin-off of the University of Geneva, developing medical imaging products and technologies.
1228 Plan-les-Ouates

Member

Rowestil Consulting GmbH

Expertise in exploratory clinical drug/diagnostic development is available across a number of disease areas. Timing of input into the developmental strategy from regulatory and commercial perspectives is important in moving development programs towards success.
6318 Walchwil

Member